17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydroxyprogesterone caproate.
Acetazolamide
The risk or severity of adverse effects can be increased when Acetazolamide is combined with Metformin.
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Metformin.
Advertisement
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Metformin.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Metformin.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Metformin.
Advertisement
Anhydrous Tacrolimus
The therapeutic efficacy of Metformin can be decreased when used in combination with Tacrolimus.
Aripiprazole
The therapeutic efficacy of Metformin can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Metformin can be decreased when used in combination with Arsenic trioxide.
Advertisement
Articaine
The therapeutic efficacy of Metformin can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Metformin can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Metformin.
Atazanavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Atazanavir.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Metformin.
Bendroflumethiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Metformin can be decreased when used in combination with Betamethasone.
Brexpiprazole
The therapeutic efficacy of Metformin can be decreased when used in combination with Brexpiprazole.
Brinzolamide
The risk or severity of adverse effects can be increased when Brinzolamide is combined with Metformin.
Bumetanide
The therapeutic efficacy of Metformin can be decreased when used in combination with Bumetanide.
Bupropion
The serum concentration of Metformin can be increased when it is combined with Bupropion.
Buserelin
The therapeutic efficacy of Metformin can be decreased when used in combination with Buserelin.
Cephalexin
The serum concentration of Metformin can be increased when it is combined with Cephalexin.
CEPHALEXIN ANHYDROUS
The serum concentration of Metformin can be increased when it is combined with Cephalexin.
Ceritinib
The therapeutic efficacy of Metformin can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Metformin may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Chlorthalidone.
Cimetidine
The serum concentration of Metformin can be increased when it is combined with Cimetidine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Metformin.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Metformin.
Citalopram
Citalopram may increase the hypoglycemic activities of Metformin.
Clozapine
The therapeutic efficacy of Metformin can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Metformin can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Metformin can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Metformin can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Metformin can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Metformin can be decreased when used in combination with Dabrafenib.
Dalfampridine
The serum concentration of Dalfampridine can be increased when it is combined with Metformin.
Danazol
The therapeutic efficacy of Metformin can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Darunavir.
Desogestrel
The therapeutic efficacy of Metformin can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Metformin.
Dexamethasone
The therapeutic efficacy of Metformin can be decreased when used in combination with Dexamethasone.
Diatrizoate
The risk or severity of adverse effects can be increased when Diatrizoate is combined with Metformin.
Diatrizoic Acid
The risk or severity of adverse effects can be increased when Diatrizoate is combined with Metformin.
Diazoxide
The therapeutic efficacy of Metformin can be decreased when used in combination with Diazoxide.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Diclofenamide is combined with Metformin.
Dienogest
The therapeutic efficacy of Metformin can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Metformin.
Disopyramide
Metformin may increase the hypoglycemic activities of Disopyramide.
Dofetilide
The serum concentration of Dofetilide can be increased when it is combined with Metformin.
Dolutegravir
The serum concentration of Metformin can be increased when it is combined with Dolutegravir.
Dorzolamide
The risk or severity of adverse effects can be increased when Dorzolamide is combined with Metformin.
Drospirenone
The therapeutic efficacy of Metformin can be decreased when used in combination with Drospirenone.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Metformin.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Metformin.
Epinephrine
The therapeutic efficacy of Metformin can be decreased when used in combination with Epinephrine.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Metformin.
Estradiol
The therapeutic efficacy of Metformin can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Metformin can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Metformin can be decreased when used in combination with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Metformin.
Ethinyl Estradiol
The therapeutic efficacy of Metformin can be decreased when used in combination with Ethinyl Estradiol.
Ethiodized Oil
The risk or severity of adverse effects can be increased when Ethiodized oil is combined with Metformin.
Ethynodiol Diacetate
The therapeutic efficacy of Metformin can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Metformin can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Metformin can be decreased when used in combination with Everolimus.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Metformin.
Fludrocortisone
The therapeutic efficacy of Metformin can be decreased when used in combination with Fludrocortisone.
Flumequine
Flumequine may increase the hypoglycemic activities of Metformin.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Metformin.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Metformin.
Fluvoxamine
Fluvoxamine may increase the hypoglycemic activities of Metformin.
Fosamprenavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Fosamprenavir.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Metformin.
Furosemide
The therapeutic efficacy of Metformin can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Metformin.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Metformin.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Metformin.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Metformin.
Gliclazide
Metformin may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Metformin may increase the hypoglycemic activities of Glimepiride.
Glipizide
Metformin may increase the hypoglycemic activities of Glipizide.
Glyburide
Metformin may increase the hypoglycemic activities of Glyburide.
Glycopyrronium
The serum concentration of Metformin can be increased when it is combined with Glycopyrronium.
Goserelin
The therapeutic efficacy of Metformin can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Metformin.
Histrelin
The therapeutic efficacy of Metformin can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Metformin can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Metformin can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Metformin can be decreased when used in combination with Indinavir.
Insulin Detemir
Metformin may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Metformin may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Metformin may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Metformin may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Metformin may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Metformin may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Metformin may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Metformin may increase the hypoglycemic activities of Insulin Lispro.
Iodipamide
The risk or severity of adverse effects can be increased when Iodipamide is combined with Metformin.
Iodixanol
The risk or severity of adverse effects can be increased when Iodixanol is combined with Metformin.
Iohexol
The risk or severity of adverse effects can be increased when Iohexol is combined with Metformin.
Iopamidol
The risk or severity of adverse effects can be increased when Iopamidol is combined with Metformin.
Iopromide
The risk or severity of adverse effects can be increased when Iopromide is combined with Metformin.
Iothalamic Acid
The risk or severity of adverse effects can be increased when Diatrizoate is combined with Metformin.
Ioversol
The risk or severity of adverse effects can be increased when Ioversol is combined with Metformin.
Ioxilan
The risk or severity of adverse effects can be increased when Ioxilan is combined with Metformin.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Metformin.
Isavuconazole
The serum concentration of Metformin can be increased when it is combined with Isavuconazole.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Metformin.
Lamotrigine
The serum concentration of Metformin can be increased when it is combined with Lamotrigine.
Lanreotide
The therapeutic efficacy of Metformin can be decreased when used in combination with Lanreotide.
Leuprolide
The therapeutic efficacy of Metformin can be decreased when used in combination with Leuprolide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Metformin.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Metformin.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Metformin.
Levonorgestrel
The therapeutic efficacy of Metformin can be decreased when used in combination with Levonorgestrel.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Metformin.
Lopinavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Lurasidone.
Mecasermin
Metformin may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Metformin may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Metformin can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Metformin can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Metformin can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Metformin.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Metformin.
Mestranol
The therapeutic efficacy of Metformin can be decreased when used in combination with Mestranol.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Metformin.
Methotrimeprazine
The therapeutic efficacy of Metformin can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Metformin.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Metformin.
Methylprednisolone
The therapeutic efficacy of Metformin can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Metformin.
Metolazone
The therapeutic efficacy of Metformin can be decreased when used in combination with Metolazone.
Mifepristone
Metformin may increase the hypoglycemic activities of Mifepristone.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Metformin.
Minaprine
Minaprine may increase the hypoglycemic activities of Metformin.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Metformin.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Metformin.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Metformin.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Metformin.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Metformin.
Nateglinide
Metformin may increase the hypoglycemic activities of Nateglinide.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Metformin.
Nelfinavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Metformin can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Metformin.
Nilotinib
The therapeutic efficacy of Metformin can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Metformin can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Metformin.
Norgestimate
The therapeutic efficacy of Metformin can be decreased when used in combination with Norgestimate.
Octreotide
The therapeutic efficacy of Metformin can be decreased when used in combination with Octreotide.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Metformin.
Olanzapine
The therapeutic efficacy of Metformin can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Metformin.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Metformin.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Metformin.
Paliperidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Metformin.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Metformin.
Pasireotide
The therapeutic efficacy of Metformin can be decreased when used in combination with Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Metformin.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Metformin.
Pentamidine
The therapeutic efficacy of Metformin can be decreased when used in combination with Pentamidine.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Metformin.
Piperazine
The therapeutic efficacy of Metformin can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Metformin can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Polythiazide.
Prednisolone
The therapeutic efficacy of Metformin can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Metformin can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Metformin.
Procaine
Procaine may increase the hypoglycemic activities of Metformin.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Metformin.
Progesterone
The therapeutic efficacy of Metformin can be decreased when used in combination with Progesterone.
Quetiapine
The therapeutic efficacy of Metformin can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Metformin can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Metformin can be decreased when used in combination with Quinethazone.
Quinine
Metformin may increase the hypoglycemic activities of Quinine.
Ranolazine
The serum concentration of Metformin can be increased when it is combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Metformin.
Regular Insulin, Human
Metformin may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Metformin may increase the hypoglycemic activities of Repaglinide.
Risperidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Ritonavir.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Metformin.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Metformin.
Saquinavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Metformin can be decreased when used in combination with Saquinavir.
Selegiline
Selegiline may increase the hypoglycemic activities of Metformin.
Sertraline
Sertraline may increase the hypoglycemic activities of Metformin.
Sirolimus
The therapeutic efficacy of Metformin can be decreased when used in combination with Sirolimus.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Metformin.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Metformin.
Sulfadiazine
Metformin may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Metformin may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Metformin may increase the hypoglycemic activities of Sulfisoxazole.
Sunitinib
Metformin may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Metformin can be decreased when used in combination with Tacrolimus.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Metformin.
Temsirolimus
The therapeutic efficacy of Metformin can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Metformin.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Metformin.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Metformin.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Metformin.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Metformin.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Metformin.
Tipiracil
The serum concentration of Tipiracil can be increased when it is combined with Metformin.
Tipranavir
The therapeutic efficacy of Metformin can be decreased when used in combination with Tipranavir.
Tolazamide
Metformin may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Metformin may increase the hypoglycemic activities of Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Metformin.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Metformin.
Torsemide
The therapeutic efficacy of Metformin can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Metformin.
Triamcinolone
The therapeutic efficacy of Metformin can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Metformin can be decreased when used in combination with Trichlormethiazide.
Trimethoprim
The serum concentration of Metformin can be increased when it is combined with Trimethoprim.
Triptorelin
The therapeutic efficacy of Metformin can be decreased when used in combination with Triptorelin.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Metformin.
Trospium
The serum concentration of Trospium can be decreased when it is combined with Metformin.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Metformin.
Vandetanib
The serum concentration of Metformin can be increased when it is combined with Vandetanib.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Metformin.
Verapamil
The therapeutic efficacy of Metformin can be decreased when used in combination with Verapamil.
Vorinostat
The therapeutic efficacy of Metformin can be decreased when used in combination with Vorinostat.
Ziprasidone
The therapeutic efficacy of Metformin can be decreased when used in combination with Ziprasidone.
